Effect of expanded genomic testing in lung adenocarcinoma (LUCA) on survival benefit: The Lung Cancer Mutation Consortium II (LCMC II) experience.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Dara Aisner, Lynette M. Sholl, Lynne D Berry, Eric B. Haura, Suresh S. Ramalingam, Bonnie S. Glisson, Mark A. Socinski, Saiama Naheed Waqar, Edward B. Garon, Jeremy Paul Cetnar, Katerina A Politi, Joan Schiller, Michael R. Rossi, Heidi Chen, John D. Minna, Ignacio Ivan Wistuba, Bruce E. Johnson, Mark G. Kris, Paul A. Bunn, David J. Kwiatkowski
Institutions: University of Colorado Anschutz, Brigham and Women's Hospital, Vanderbilt University, Moffitt Cancer Center, Emory University, Winship Cancer Institute, The University of Texas MD Anderson Cancer Center, University of Pittsburgh, Washington University in St. Louis, University of California, Los Angeles, Oregon Health & Science University, Yale University, The University of Texas Southwestern Medical Center, Vanderbilt-Ingram Cancer Center, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, University of Colorado Denver
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890170641